Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Director dealings: Currys CFO lowers stake

(Sharecast News) - Currys revealed on Friday that chief financial officer Bruce Marsh had disposed of 500,000 ordinary shares in the FTSE 250-listed electrical goods retailer. Marsh, who joined the company in July 2021, sold the shares at an average price of 146.26p each, for a total value of £731,337.50.

Following the sale, Marsh holds a beneficial interest in 1.68m ordinary Currys shares.

As of 1530 BST, Currys shares were up 0.13% at 151.10p.

Reporting by Iain Gilbert at Sharecast.com

Top Director Buys

Acceler8 Ventures (AC8) Director name: Rudd,Nigel Amount purchased: 25,000 @ 60p Value: £15,000.00

Top Director Sells

Currys (CURY) Director name: Marsh,Bruce Amount sold: 321,514 @ 146.35p Value: £470,522.87

Currys (CURY) Director name: Marsh,Bruce Amount sold: 155,000 @ 146.16p Value: £226,548.31

Currys (CURY) Director name: Marsh,Bruce Amount sold: 23,486 @ 145.90p Value: £34,266.07

Share this article

Related Sharecast Articles

Director dealings: Rosebank chairman raises stake
(Sharecast News) - Rosebank Industries revealed on Friday that chairman Justin Dowley had acquired 161,576 ordinary shares in the FTSE 250-listed turnaround specialist.
Director dealings: IQE director snaps up shares
(Sharecast News) - IQE revealed on Thursday that non-executive director Robert Dennehy had acquired 468,817 ordinary shares in the AIM-listed semiconductor wafers and materials solutions supplier.
Director dealings: Everyman Media's Dorfman snaps up shares
(Sharecast News) - Everyman Media revealed on Wednesday that interim creative director Charles Dorfman had acquired 925,000 ordinary shares in the AIM-listed cinema operator.
Director dealings: Accler8 chairman raises stake
(Sharecast News) - Acceler8 Ventures revealed on Tuesday that chairman Nigel Rudd had acquired 121,429 ordinary shares in the London-listed life sciences business.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.